Back to Trials
NCT04228367NARecruiting

JuggerStitch Post Market Clinical Follow-up Study

Zimmer Biomet

Start Date

9/25/2020

Completion Date

4/30/2026

Summary

This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).

Detailed Description

This study is a post-market follow-up study to fulfil the post-market surveillance obligations according to Medical Device Directive and MEDDEV 2.12/2 and the Medical Devices Regulation (MDR 2017/745). The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (IFU). The objectives of the study are to calculate the overall clinical success rate and the performance, and confirm the safety of the JuggerStitch Meniscal Repair Device. The primary endpoint of this study is defined by the absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Subject qualifies for meniscal repair based on the physical exam and medical history and meets the approved indications for use of the study product; * Older than 18 years and skeletally mature; * Willing and able to comply with the study procedures; * Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program; * Subject is able to read and understand the informed consent form (ICF) and has voluntarily provided written informed consent. Exclusion Criteria: * Meniscal tears in the avascular zone of meniscus; * Meniscal tears not suitable for repair because of the degree of damage(marked irregularity and complex tearing) to the meniscus body including degenerative, radial, horizontal cleavage and flap tears; * Presence of active infection; * If female, subject is pregnant; * Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant); * The subject is unwilling or unable to give consent or to comply with the follow-up program; * Subject meets any contraindications of the appropriate Instruction for Use.

Interventions

DEVICE

JuggerStitch Meniscal Repair Device

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Meniscus Tear, TibialMeniscus Lesion

Locations

OrthoCarolina

Charlotte, North Carolina 28207

United States

OrthoVirginia, Inc.

Richmond, Virginia 23226

United States

Ramsay General de Sante - Hôpital Privé Jean Mermoz - Centre Orthopédique Santy

Lyon, 69008

France

Medizinische Fakultät der Otto-von-Guericke-Universität Magdeburg

Magdeburg, 39120

Germany

Ichihara Hospital

Tsukuba, Ibaraki 300-3295

Japan

Tokyo Medical and Dental University Hospital of Medicine

Tokyo, 113-8519

Japan